The preparation for the commencement of this P2 for GVHD with the FDA seems rigorous and exhausting!!
I can’t wait!
The can just got kicked down the road. Again.
Confirmation that they have more than enough funds to complete the P2 GVHD trial with the FDA. Totally outsourced (as per previous announcements) by the new leader.
Ok then.
I can’t wait. Still!
Ann: Strategic Review of Cynata Clinical Development Portfolio, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22561 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 13572 | 2 |
View Market Depth
| Last trade - 11.38am 27/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable